Market News & Trends
Strength of Aptalis Pharmaceutical Technologies Patents Confirmed by AMRIX Verdict
Aptalis Pharmatech, Inc. (previously known as Eurand, Inc.); Cephalon, Inc., a wholly owned subsidiary of Teva Pharmaceuticals Industries Ltd; and Anesta AG prevailed in their…
Ypsomed Launches New Commercial Product
Ypsomed recently announced it is expanding its mylife product range with the innovative self-injection system mylife DailyDose, which will initially be sold in six European…
3M DDS to Enhance Manufacturing Capabilities
3M Drug Delivery Systems recently announced the expansion of the pressurized metered dose inhaler (pMDI) fill line at its facility in Northridge, CA, significantly extending the company's…
5/1/2012
3M DDS to Enhance Manufacturing Capabilities 3M Drug Delivery Systems recently announced the expansion of the pressurized metered dose inhaler (pMDI) fill line at its facility in…
AAIPharma Services Opens New Technology Center, Will Add Jobs
AAIPharma Services Corp. officially opened a 40,000-sq-ft, state-of-the-art Technology Center on its Wilmington, NC, headquarters campus as part of a $15-million capital expansion program. The…
4/25/2012
Alitair Announces Patent Allowance for Platform Delivery Technology Alitair Pharmaceuticals, Inc., a mid-stage pharmaceutical company with multiple respiratory product candidates in development, recently announced it…
Alitair Announces Patent Allowance for Platform Delivery Technology
Alitair Pharmaceuticals, Inc., a mid-stage pharmaceutical company with multiple respiratory product candidates in development, recently announced it has received a Notice of Allowance from the…
Baxter International's New Plant to Bring 1,500 High-Paying Jobs
Baxter International Inc. recently announced it will build a new state-of-the-art manufacturing facility in Georgia to support growth of its plasma-based treatments. These therapies include…
EMD Millipore Launches Model for In Vitro Transdermal Diffusion Studies
EMD Millipore recently introduced Strat-M membrane for screening compounds and formulations via in vitro diffusion studies. The synthetic membrane can be successfully used in place…
Idenix Provides Update on Clinical Development Programs
Idenix Pharmaceuticals, Inc. recently announced data from a Phase I clinical trial of IDX719, an NS5A inhibitor for the treatment of hepatitis C virus (HCV)…
NuSil Technology Announces Major Expansion
NuSil Technology LLC, the global leader in silicone materials for the healthcare, aerospace, pharmaceutical, aircraft, and drug delivery industries, recently announced plans for a major…
Spinnovation Biologics Predicts Biomanufacturing Success
With expertise and know-how in high-end analysis for biologics, Spinnovation Biologics recently announced the launch of a breakthrough solution -Spedia-Predict- for Bioprocess performance troubleshooting and…
SeraCare Expands AccuCell Line With Human Cord Blood Mononuclear Cells
SeraCare Life Sciences recently announced it has expanded its line of AccuCell mononuclear cells with the launch of off-the-shelf Human Cord Blood Mononuclear Cells (CBMNCs).…
US CMO Market Revives as Pharma Companies Increasingly Outsource
The upturn in the fortunes of pharmaceutical companies after the recession is mirrored by the US CMO market, which is expected to grow at a…
4/17/2012
Ei Increases Capabilities Through New Partnership Ei, A Pharmaceutical SolutionWorks, recently announced a new partnership with KeraNetics. Ei has begun a $13.2-million expansion within their…
Ei Increases Capabilities Through New Partnership
Ei, A Pharmaceutical SolutionWorks, recently announced a new partnership with KeraNetics. Ei has begun a $13.2-million expansion within their recently completed 147,000-sq-ft facility in Kannapolis,…
Horizon Partners With EMQN to Minimize Variability in Cancer Diagnostic Testing
Horizon Diagnostics (HDx), a division of Horizon Discovery Limited, a leading provider of research tools to support the development and prescription of personalized medicines, recently…
Nascent & Catalent Sign Cancer Antibody Development Deal
Nascent Biologics, Inc. and Catalent Pharma Solutions recently announced the signing of a product development agreement. Under the terms of the agreement, Catalent will engineer…
QRxPharma Successfully Completes Phase I Studies
QRxPharma recently announced successful completion of two Phase I studies in healthy volunteers for MoxDuo CR, a controlled-release Dual-Opioid utilizing a 3:2 ratio of morphine…
4/10/2012
Catalent & BASF Join Forces to Solve Bioavailabilty Challenges Catalent Pharma Solutions and BASF recently announced they have entered into a broad collaboration and Open…
